ClinicalTrials.gg
Sign In
Status unknownNCT05823792PAITUWDSUpdated Apr 21, 2023

Performance of Artificial Intelligence Tools and Ultrasonographers With Different Skills

An observational study in Ileocolic Intussusception, sponsored by Hongkui Yu， MD. Status unknown at 1 site in China. Open to participants aged 3 Months to 36 Months, including healthy volunteers. Per ClinicalTrials.gov, last updated 2023-04-21.

Sponsored by Hongkui Yu， MD · Observational

The sponsor has not verified this record recently (last verified Apr 2023), so the status shown — last known as Recruiting — may be out of date.
Study type
Observational
Model
Other
Time perspective
Prospective
Enrollment
250
Ages
3 Months to 36 Months
Sex
All
01

Study summary

Artificial intelligence versus different skilled sonographers.

Read the detailed description

Comparison of artificial intelligence and ultrasonographers with different skills in diagnosing intussusception in children and identifying indications for surgery.

02

Conditions studied

  • Ileocolic Intussusception

Browse trials for

03

In context

Intussusception

31 studies on the registry are indexed under Intussusception; 6 are open to participants now.

This study's planned enrollment of 250 is close to the median of 250 across 15 observational studies indexed under Intussusception.

Browse Intussusception studies →

Lead sponsor

This is the only study on the registry with Hongkui Yu， MD as lead sponsor.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
3 Months to 36 Months
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Non-probability sample

Study population

Children aged 3-36 months with suspected ileocolic intussusception

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Children aged 3-36 months with suspected ileocolic intussusception

Exclusion criteria

Exclusion Criteria:

  • Children younger than 3 months or older than 36 months with suspected ileocolic intussusception
05

Study design

Observational model
Other
Time perspective
Prospective
Enrollment
250 participants (estimated)
Patient registry
No
Biospecimen retention
Samples without dna

Groups and cohorts

  • Patients aged 3-36 months with suspected ileocolic intussusception

    Patients aged 3-36 months with suspected ileocolic intussusception

    Diagnostic Test: Non-invasive diagnosis of ileocolic intussusception by ultrasound with indication for surgery

Interventions

  • Diagnostic testNon-invasive diagnosis of ileocolic intussusception by ultrasound with indication for surgery

    Non-invasive diagnosis of ileocolic intussusception by ultrasound with indication for surgery

06

What researchers measure

Primary outcomes

  1. Ultrasound diagnosis of ileocolic intussusception

    Ultrasound diagnosis of ileocolic intussusception

    Time frame: April 9, 2023 to May 10, 2023

Secondary outcomes

  1. Surgical indication of ileocolic intussusception identified by ultrasound

    Surgical indication of ileocolic intussusception identified by ultrasound

    Time frame: April 9, 2023 to May 10, 2023

07

Study locations

1 of 1 sites recruiting
  • Hongkui Yu， MD
    Guangzhou, Guangdong 510623, China
    Recruiting
08

References and documents

Individual participant data

Plan to share: Yes — For non-commercial use in research, you can contact Prof. Hongkui Yu to get the data at hongkuiyu@126.com.

Supporting information: Study protocol, Statistical analysis plan, Analytic code

Time frame: After May 20, 2023

Access criteria: For non-commercial use in research, you can contact Prof. Hongkui Yu to get the data at hongkuiyu@126.com.

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Started Apr 2023 (actual). Primary completion is estimated for May 2023, 1 month after the start.

How these figures are worked out, and which studies are left out of them.

Registered
Apr 9, 2023
First posted
Apr 21, 2023
StartActual
Apr 9, 2023
Primary completionEst.
May 10, 2023
CompletionEst.
May 10, 2023
Last update
Apr 21, 2023
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Apr 21, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05823792
Lead sponsor
Hongkui Yu， MD
Responsible party
Hongkui Yu， MD (Chief Physician, Guangzhou Women and Children's Medical Center) — Sponsor-investigator
First posted
Apr 21, 2023
Start date
Apr 9, 2023
Primary completion
May 10, 2023 (estimated)
Completion
May 10, 2023 (estimated)
Last update
Apr 21, 2023

Study contacts

Hongkui Yu
Contact
hongkuiyu@126.com
+86 18938691272
Hongkui Yu，
principal investigator · Guangzhou Women and Children's Medical Center

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Apr 2023. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Other studies in this condition

Intussusception →

Start the discussion